tadalafil has been researched along with tetracaine in 1 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (tetracaine) | Trials (tetracaine) | Recent Studies (post-2010) (tetracaine) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 2,688 | 349 | 274 |
Protein | Taxonomy | tadalafil (IC50) | tetracaine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 3.268 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.317 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.415 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 3.268 | |
Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | 0.056 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 0.5075 | |
Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 1.4693 | |
Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 0.795 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.673 | |
Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | 0.74 | |
Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | 0.52 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L | 1 |
1 other study(ies) available for tadalafil and tetracaine
Article | Year |
---|---|
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG | 2008 |